

Should you need a unique or custom configuration, your IT administrators will enjoy our detailed documentation to help set that up. Furthermore, the QIAGEN CLC Genomics Cloud Engine Command Line Tools provide a second means to use QIAGEN CLC Genomics Cloud Engine for advanced bioinformatics users.
#QIAGEN CLC GENOMICS WORKBENCH FULL#
The QIAGEN CLC Genomics Cloud Engine has a full RESTful API that enables enterprise customers to fully integrate their cloud computing needs into their existing IT architecture.

Need to integrate with an existing IT infrastructure? No problem. If you need a smaller environment for development, or want to test the waters of AWS before deploying at a larger scale, this version is perfect for you. The QIAGEN CLC Genomics Cloud Engine Staging-License is restricted to running on only three AWS instances at once, but at a substantially reduced price. Not ready for a full QIAGEN CLC Genomics Cloud Engine deployment? Ask about our limited Staging Environment distribution.

#QIAGEN CLC GENOMICS WORKBENCH SOFTWARE#
Introducing QCI Interpret One, clinical decision support software with professional i. QCI Interpret One – Oncology variant interpretation just got more precise.Catalogue of Somatic Mutations in Cancer (COSMIC) – Explore the impact of somatic mutations in human cancer with the world’s largest and most comprehensive resource.Clinical Analysis and Interpretation Services.Pharmaceutical Development Bioinformatic Services.QIAGEN Discovery Bioinformatics Services.QIAGEN CLC Genomics Workbench – QIAGEN CLC Genomics Workbench is a powerful solution that works for everyone, no matter the workflow.Human Gene Mutations Database (HGMD) – Solve more cases faster, with data you can trust using HGMD Professional, the gold standard for identifying inherited disease-causing mutati.QIAseq panels | QIAGEN Digital Insights.Clinical QKB (Clinical QIAGEN Knowledge Base).COSMIC (Catalogue of Somatic Mutations in Cancer).Learn more about its role in oncogenesis and ac. Know your biomarkers: PRKD1 linked to head and neck cancer? – A new cancer gene, PRKD1, has been identified as defining a subset of head and neck cancers.Stop looking for a needle in a haystack – Easily accelerate biomarker and target discovery by exploring and interpreting your data with intuitive, visual biomarker identification too.Single-Cell Genomic Solutions – Explore our powerful solutions for the analysis and interpretation of single-cell gene expression analysis and genomics.Pharmaceutical Development – Whether searching for clinically applicable biomarkers, designing a new companion diagnostic (CDx), or honing your study accrual and go-to-m.Research & Discovery – Powerful digital insights to help you innovate, integrate and translate scientific results into impactful discoveries.
